Q&A with Andy Hanson Head of Equity Research at Zeus Capital: Epwin Group PLC (LON:EPWN)
Zeus Capital’s Andy Hanson discusses Epwin Group PLC in this exclusive interview with DirectorsTalk
Zeus Capital’s Andy Hanson discusses Epwin Group PLC in this exclusive interview with DirectorsTalk
Zeus Capital’s Andy Hanson discusses Flowtech Fluidpower PLC in this exclusive interview with DirectorsTalk
Zeus Capital’s Mike Allen discusses Harvey Nash Group plc in this exclusive interview with DirectorsTalk
Deltex Medical Group’s Ewan Phillips discusses their interim results for the six months ended 30 June 2017 in this exclusive interview with DirectorsTalk
Zeus Capital’s John Wilson discusses Centralnic Group PLC in this exclusive interview with DirectorsTalk
Advanced Oncotherapy plc (LON:AVO) Chief Operating Officer Ed Lee talks to DirectorsTalk about his background, what that experience brings to AVO and how that knowledge can translate into shareholder value.
Falanx Group’s Richard Morrell discusses the driving factors for joining Falanx, competition in the marketplace and where he sees the growth for MidGARD in this exclusive interview with DirectorsTalk
Centralnic Group’s Ben Crawford discusses their interim results to 30th June 2017 in this exclusive interview with DirectorsTalk
Vipera’s Martin Perrin discusses their interim results for the six months ended 30th June 2017 in this exclusive interview with DirectorsTalk
Lighthouse Group’s Malcolm Streatfield discusses their interim results for the six months ended 30th June 2017 in this exclusive interview with DirectorsTalk